Literature DB >> 9397038

Mammographic screening: results from the 1996 National Breast Health Survey.

A L Barratt1, J Cockburn, S Redman, C Paul, J Perkins.   

Abstract

OBJECTIVE: To establish the extent of women's knowledge of mammographic screening, particularly in relation to the national screening program, BreastScreen Australia, and to estimate the proportion of women who are participating in screening both within and outside BreastScreen Australia. DESIGN AND
SETTING: Validated prospective telephone survey of women aged 30-69 years selected at random from across Australia. PARTICIPANTS: 2935 women with no previous breast cancer diagnosis.
RESULTS: The adjusted response rate was 64%. Almost 90% of women had heard of the national program; only 1% correctly stated that screening is for asymptomatic women. 60% correctly identified the current recommended age of starting screening is about 50 years of age; 26% thought screening should begin at about 40 years of age. Approximately 60% correctly reported that the recommended screening interval is every two years; 27% thought screening should be done annually. 55% reported ever having had a mammogram, and 37% reported having had at least one screening mammogram. Among women in the target age group (50-69 years) about 70% reported ever having had a screening mammogram, and about 50% reported having had a screening mammogram within the national program in the last two years. Among women aged 40-49 years, 29% reported ever having had a screening mammogram, and 22% reported having been screened in the last two years.
CONCLUSIONS: Awareness of the national screening program is high, but some women do not know the purpose of screening, the target age group and the recommended screening interval. Compliance with screening is good among women in the target age group; many women in their 40s are also participating in screening.

Entities:  

Mesh:

Year:  1997        PMID: 9397038     DOI: 10.5694/j.1326-5377.1997.tb138871.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

1.  Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results.

Authors:  Heather M Davey; Alexandra L Barratt; Elizabeth Davey; Phyllis N Butow; Sally Redman; Nehmat Houssami; Glenn P Salkeld
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

2.  Perceived sensitivity of mammographic screening: women's views on test accuracy and financial compensation for missed cancers.

Authors:  A Barratt; J Cockburn; C Furnival; A McBride; L Mallon
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

3.  Content of invitations for publicly funded screening mammography.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2006-03-04

Review 4.  Understanding the effects of socioeconomic status along the breast cancer continuum in Australian women: a systematic review of evidence.

Authors:  Greg Lyle; Gilly A Hendrie; Delia Hendrie
Journal:  Int J Equity Health       Date:  2017-10-16

5.  Variations in outcomes by residential location for women with breast cancer: a systematic review.

Authors:  Paramita Dasgupta; Peter D Baade; Danny R Youlden; Gail Garvey; Joanne F Aitken; Isabella Wallington; Jennifer Chynoweth; Helen Zorbas; Philippa H Youl
Journal:  BMJ Open       Date:  2018-04-29       Impact factor: 2.692

Review 6.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

7.  The 2003 Australian Breast Health Survey: survey design and preliminary results.

Authors:  Elmer V Villanueva; Sandra Jones; Caroline Nehill; Simone Favelle; David Steel; Donald Iverson; Helen Zorbas
Journal:  BMC Public Health       Date:  2008-01-14       Impact factor: 3.295

8.  Health information provision, health knowledge and health behaviours: Evidence from breast cancer screening.

Authors:  Peter Eibich; Léontine Goldzahl
Journal:  Soc Sci Med       Date:  2020-11-09       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.